C Bergquist

No ORCID on file · 7 papers in corpus · active 1984-2000

Study types

  • article 7

Condition tags

  • endometriosis 7
  • infertility 2
  • mesh:D004716 1
article 2000
[Current aspects on the treatment of endometriosis].
Lakartidningen

The aim of pharmacological treatment of endometriosis is to reduce estrogen levels, which may be achieved using gestagens or GnRH-agonists. The effects of the different hormones are mainly the same, while side effects differ. If the GnRH-ag…

article 2000
[Endometriosis--an inflammatory disease in women. Pain and reduced fertility are serious symptoms].
Lakartidningen

Endometriosis is a common disease with serious consequences for the patient and for society. Until now there has been no reliable method for diagnosing endometriosis besides direct visualization, e.g. utilizing laparoscopy. IVF offers the m…

article 1997
Therapeutic efficacy and bone mineral density response during and following a three-month re-treatment of endometriosis with nafarelin (Synarel)
American Journal of Obstetrics and Gynecology ·doi:10.1016/s0002-9378(97)70084-x
article 1991
[Endometriosis and infertility].
Lakartidningen
article 1990
Effects of nafarelin versus danazol on lipids and calcium metabolism
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(90)90438-d
article 1989
Clinical experience treating endometriosis with nafarelin.
The Journal of reproductive medicine

The preliminary results from an ongoing multicenter trial further support the efficacy and excellent tolerability of nafarelin in the management of endometriosis.

article 1984
A New Superagonist of GnRH for Inhibition of Ovulation in Women
Upsala journal of medical sciences ·doi:10.3109/03009738409178474

This paper presents the initial results from a study that used a new superagonist of gonadotrophin-releasing hormone (GnRH), naferelin acetate, for the inhibition of ovulation. The superagonist was administered by nasal spray daily for 12 w…